ArticleFrontiers in pharmacology2022

Immune Checkpoint Inhibitors Plus an Anti-VEGF Antibody as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis.

Lu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.